On 23 December 2019, the Global Fund Board approved by electronic vote funding for interventions from the Register of Unfunded Quality Demand (UQD) valued at $18,449,708 for four grants in four countries. The funds come from $650 million approved by the Audit and Finance Committee for portfolio optimization, from the 2017-2019 allocations. The additional amounts will be integrated into four…
If Indonesia’s HIV- and TB-program targets are to be reached by 2020, the design of both programs needs improvement, the Office of the Inspector General said, emphasizing shortcomings in the HIV program in particular. This was the second OIG audit of Indonesia’s Global Fund grants since the Global Fund’s investments in the country began, in 2003. The OIG report, published…
Transition and sustainability are critical issues in Latin America and the Caribbean (LAC), and Global Fund-supported mechanisms in the region need to be better harmonized, concludes a new report, ‘Optimizing the Global Fund Resources’. The report was commissioned in March 2019, jointly by the LAC delegation to the Global Fund Board and the Horizontal Technical Cooperation Group (HTCG), a LAC initiative…
According to the Global Fund to Fight AIDS, Tuberculosis, and Malaria’s recently published Eligibility 2020 list, the list of countries and disease components currently eligible for Global Fund support, 131 countries are eligible to receive an allocation from the Global Fund during the 2020–2022 period. However, this eligibility does not automatically result in an allocation as countries still need to apply…
During the last decade, the world recorded substantial progress in the fight against the global HIV epidemic: AIDS-related deaths reduced by one third, and new HIV infections reduced by a 16%, between 2010 and 2018. However, dwindling financial resources available for HIV and a growing epidemic in some regions, such as Eastern Europe and Central Asia, threaten these gains, which…
Subscribe to our newsletter below and never miss the latest updates.
Subscribe to our weekly newsletter below.
